SCHEMBL31269179

SCHEMBL31269179

Cc1nc(Cn2c(-c3ccc(CC(N)=O)cc3Cl)nc3c(OC4(C)CC4)ncnc32)cs1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.35
▸ DGAT1 O75907 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ KLKB1 P03952 6/20 0.32
▸ KLK1 P06870 6/20 0.32
▸ DCTPP1 Q9H773 1/20 0.32
▸ PARG Q86W56 1/20 0.31
▸ RET P07949 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ ALOX5AP P20292 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ PKM P14618 1/20 0.30
▸ PTGDR2 Q9Y5Y4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269283 0.90 PIK3CD (0.38) PIK3CDDGAT1SMN1; SMN2CNR1CNR2
SCHEMBL31269332 0.89 PIK3CD (0.36) PIK3CDDGAT1CNR1CNR2
SCHEMBL30983484 0.89 PIK3CD (0.36) PIK3CDDGAT1SCN5ASCN9ACNR1
SCHEMBL30983368 0.89 PIK3CD (0.36) PIK3CDDGAT1CNR1CNR2
SCHEMBL31269290 0.88 PIK3CD (0.37) PIK3CDDGAT1CNR1CNR2
SCHEMBL31269129 0.88 PIK3CD (0.35) PIK3CDDGAT1SCN5ASCN9AALOX5AP
SCHEMBL31268788 0.88 PIK3CD (0.37) PIK3CDDGAT1SCN9ACNR1CNR2
SCHEMBL31269497 0.87 PIK3CD (0.35) PIK3CDDGAT1PARGCNR1CNR2
SCHEMBL31269311 0.87 PIK3CD (0.35) PIK3CDDGAT1CNR1CNR2
SCHEMBL31269255 0.87 PDE10A (0.38) PIK3CDDGAT1DCTPP1CNR1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback